-
EP3787689
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP3787689
| EP3787689 - DRUG DELIVERY [Right-click to bookmark this link] | Status | Request for examination was made Status updated on 05.02.2021 Database last updated on 13.11.2024 | |
| Former | The international publication has been made Status updated on 08.11.2019 | ||
| Former | unknown Status updated on 20.05.2019 | Most recent event Tooltip | 18.03.2024 | New entry: Renewal fee paid | Applicant(s) | For all designated states Oxford University Innovation Limited Buxton Court 3 West Way Oxford, Oxfordshire OX2 0JB / GB | [2021/10] | Inventor(s) | 01 /
ANTHONY, Daniel Department of Pharmacology Mansfield Road Oxford Oxfordshire OX1 3QT / GB | 02 /
DAVIS, Ben Chemistry Search Laboratory 12 Mansfield Road Oxford Oxfordshire OX1 3QT / GB | 03 /
WALS, Kim Department of Pharmacology Mansfield Road Oxford Oxfordshire OX1 3QT / GB | 04 /
AKBAR, Naveed Radcliffe Department of Medicine University of Oxford University Innovation Ltd. Level 6, West Wing, John Radcliffe Hospital Headington, Oxford Oxfordshire OX3 9DU / GB | 05 /
SEALEY, Megan Department of Pharmacology Mansfield Road Oxford Oxfordshire OX1 3QT / GB | [2021/10] | Representative(s) | J A Kemp LLP 80 Turnmill Street London EC1M 5QU / GB | [N/P] |
| Former [2021/10] | J A Kemp LLP 14 South Square Gray's Inn London WC1R 5JJ / GB | Application number, filing date | 19723162.4 | 30.04.2019 | [2021/10] | WO2019GB51195 | Priority number, date | GB20180007040 | 30.04.2018 Original published format: GB 201807040 | [2021/10] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2019211595 | Date: | 07.11.2019 | Language: | EN | [2019/45] | Type: | A1 Application with search report | No.: | EP3787689 | Date: | 10.03.2021 | Language: | EN | The application published by WIPO in one of the EPO official languages on 07.11.2019 takes the place of the publication of the European patent application. | [2021/10] | Search report(s) | International search report - published on: | EP | 07.11.2019 | Classification | IPC: | A61K47/54, A61K47/69, A61P25/00 | [2021/10] | CPC: |
A61K47/6911 (EP,US);
A61K47/549 (EP,US);
A61K45/06 (US);
A61P25/00 (EP);
B82Y5/00 (US)
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2021/10] | Title | German: | ARZNEIMITTELABGABE | [2021/10] | English: | DRUG DELIVERY | [2021/10] | French: | ADMINISTRATION DE MÉDICAMENT | [2021/10] | Entry into regional phase | 11.11.2020 | National basic fee paid | 11.11.2020 | Designation fee(s) paid | 11.11.2020 | Examination fee paid | Examination procedure | 11.11.2020 | Examination requested [2021/10] | 11.11.2020 | Date on which the examining division has become responsible | 18.06.2021 | Amendment by applicant (claims and/or description) | Fees paid | Renewal fee | 27.04.2021 | Renewal fee patent year 03 | 20.04.2022 | Renewal fee patent year 04 | 19.04.2023 | Renewal fee patent year 05 | 18.03.2024 | Renewal fee patent year 06 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [XI]US2009186073 (YAMAZAKI NOBORU [JP], et al) [X] 1,5-15,17,18 * Liposomes No. 22, 69, 191, 209, 288;; examples 1-7,11-17; table 12 * * paragraph [0466] * [I] 2-4,16,19,20; | [X] - KAWAUCHI YOKO ET AL, "Comparison of the carbohydrate preference of SIGNR1 as a phagocytic receptor with the preference as an adhesion molecule", INTERNATIONAL IMMUNOPHARMACOLOGY, ELSEVIER, AMSTERDAM, NL, (20140113), vol. 19, no. 1, doi:10.1016/J.INTIMP.2013.12.030, ISSN 1567-5769, pages 27 - 36, XP028618211 [X] 1,5-15,17 * Section 2.1. "Cells and materials" * DOI: http://dx.doi.org/10.1016/j.intimp.2013.12.030 | [X] - ZHU ET AL, "Vesicle size and stability of biomimetic liposomes from 3'-sulfo-Lewis a (SuLe) containing glycolipids", COLLOIDS AND SURFACES. B, BIOINTERFACES, ELSEVIER, AMSTERDAM, NL, (20070619), vol. 58, no. 2, doi:10.1016/J.COLSURFB.2007.03.016, ISSN 0927-7765, pages 242 - 249, XP022121444 [X] 1,3 * figure 1 * DOI: http://dx.doi.org/10.1016/j.colsurfb.2007.03.016 | [X] - Sigma-Aldrich, "Glycobiology and Glycoproteomics", (20110101), pages 1 - 12, URL: https://www.sigmaaldrich.com/content/dam/sigma-aldrich/docs/Sigma/Brochure/1/glycobiology_brochure.pdf, (20190725), XP055609022 [X] 1,5-15,17 * Section "Cell Surface Modification" * | by applicant | - AKBARZADEH et al., Nanoscale Res Lett, (20130000), vol. 8, no. 1, page 102 |